Yonsei Med J.  2014 Jul;55(4):920-927. 10.3349/ymj.2014.55.4.920.

Clinical Outcomes of Patients with Acute Myocardial Infarction Complicated by Severe Refractory Cardiogenic Shock Assisted with Percutaneous Cardiopulmonary Support

• Park TK
• Yang JH
• Choi SH
• Song YB
• Hahn JY
• Choi JH
• Sung K
• Lee YT
• Gwon HC
• Lee SH

• KMID: 2130815
• DOI: http://doi.org/10.3349/ymj.2014.55.4.920

Abstract

PURPOSE
Limited data are available on the role of percutaneous cardiopulmonary support (PCPS) for the treatment of acute myocardial infarction (AMI) patients with cardiogenic shock. We investigated the clinical outcomes and predictors of in-hospital mortality after PCPS in patients with AMI complicated by severe refractory cardiogenic shock.
MATERIALS AND METHODS
From January 2004 to December 2011, we analyzed data from 96 consecutive AMI patients with cardiogenic shock assisted by a PCPS system. The primary outcome was in-hospital mortality. The predictors of in-hospital mortality were determined by a Cox proportional-hazards model.
RESULTS
In-hospital mortality occurred in 51 (53.1%) patients and 58 (60.4%) patients were able to be weaned from PCPS. Cardiopulmonary resuscitation (CPR) was performed in 61 (63.5%) patients before PCPS initiation. On multivariate analysis, age > or =67 years [adjusted hazard ratio (HR), 4.74; 95% confidence interval (CI), 2.27-9.93; p<0.001], CPR (adjusted HR, 2.32; 95% CI, 1.11-4.85; p=0.03), lactate clearance for 48 hours <70% (adjusted HR, 2.50; 95% CI, 1.04-6.05; p=0.041), and unsuccessful revascularization (adjusted HR, 3.57; 95% CI, 1.85-6.90; p=0.002) were independent predictors of in-hospital mortality after PCPS in patients with AMI complicated by cardiogenic shock.
CONCLUSION
In spite of PCPS management, AMI patients complicated by severe refractory cardiogenic shock demonstrated high mortality. Older age, CPR, lower lactate clearance for 48 hours, and unsuccessful revascularization were independent predictors of in-hospital mortality.

Keyword

Myocardial infarction; cardiogenic shock; percutaneous cardiopulmonary support

MeSH Terms

Aged
Cardiopulmonary Bypass
Cardiopulmonary Resuscitation
Female
Humans
Male
Middle Aged
Myocardial Infarction/*complications/*mortality/surgery/therapy
Shock, Cardiogenic/*complications
Treatment Outcome

Figure

• 

  Fig. 1 Kaplan-Meier survival curve. (A) Kaplan-Meier survival curve for all patients. (B) Kaplan-Meier survival curve for age <67 years (solid line) versus age ≥67 years (dashed line). (C) Kaplan-Meier survival curve for lactate clearance for 48 hours ≥70% (solid line) versus lactate clearance for 48 hours <70% (dashed line). (D) Kaplan-Meier survival curve for successful revascularization (solid line) versus unsuccessful revascularization (dashed line).

Reference

1. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999; 341:625–634.

2. Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, et al. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002; 90:838–842.

3. Cove ME, MacLaren G. Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction. Crit Care. 2010; 14:235.

4. Chung SY, Sheu JJ, Lin YJ, Sun CK, Chang LT, Chen YL, et al. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study. Circ J. 2012; 76:1385–1392.

5. Shin TG, Choi JH, Jo IJ, Sim MS, Song HG, Jeong YK, et al. Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation. Crit Care Med. 2011; 39:1–7.

6. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119:1211–1219.

7. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005; 294:448–454.

8. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367:1287–1296.

9. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009; 30:459–468.

10. Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30:2102–2108.

11. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011; 57:688–696.

12. Sung K, Lee YT, Park PW, Park KH, Jun TG, Yang JH, et al. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support. Ann Thorac Surg. 2006; 82:651–656.

13. Kim H, Lim SH, Hong J, Hong YS, Lee CJ, Jung JH, et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation. 2012; 83:971–975.

14. Morisawa D, Higuchi Y, Iwakura K, Okamura A, Date M, Ohmiya S, et al. Predictive factors for successful weaning from percutaneous cardiopulmonary support in patients with cardiogenic shock complicating acute myocardial infarction. J Cardiol. 2012; 60:350–354.

15. Tsao NW, Shih CM, Yeh JS, Kao YT, Hsieh MH, Ou KL, et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. J Crit Care. 2012; 27:530.

16. Sakamoto S, Taniguchi N, Nakajima S, Takahashi A. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Ann Thorac Surg. 2012; 94:1–7.

17. Kagawa E, Dote K, Kato M, Sasaki S, Nakano Y, Kajikawa M, et al. Should we emergently revascularize occluded coronaries for cardiac arrest?: rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circulation. 2012; 126:1605–1613.

18. Rees MR, Browne T, Sivananthan UM, Whittaker S, Hick D, Verma SP, et al. Cardiac resuscitation with percutaneous cardiopulmonary support. Lancet. 1992; 340:513–514.

19. Wu MY, Tseng YH, Chang YS, Tsai FC, Lin PJ. Using extracorporeal membrane oxygenation to rescue acute myocardial infarction with cardiopulmonary collapse: the impact of early coronary revascularization. Resuscitation. 2013; 84:940–945.

20. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004; 32:1637–1642.

21. Attaná P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study. Acute Card Care. 2012; 14:20–26.

22. Jo IJ, Shin TG, Sim MS, Song HG, Jeong YK, Song YB, et al. Outcome of in-hospital adult cardiopulmonary resuscitation assisted with portable auto-priming percutaneous cardiopulmonary support. Int J Cardiol. 2011; 151:12–17.